Follow-up of operable breast cancer patients takes up a significant proportion of British oncologists'time, with 90% seeing 5-50 patients each week.
Procedures vary greatly, but, in patients treated by surgery and radiotherapy, care is usually shared, with alternating visits to see each team.
Currently, the general practitioner has sole responsibility for follow-up in less than 3% of patients.
They tend to be followed up in general, rather than specialist, clinics.
There is almost universal agreement that routine blood tests, radiographs and scans are not indicated as part of routine follow-up, but the role of mammography in evaluating an irradiated breast remains a source of debate.
Just over a half of the oncologists surveyed order baseline mammography of both treated and contralateral breasts, usually between 6 and 12 months after local excision and radiotherapy, with further follow-up 1-3-yearly thereafter.
Ten per cent of the participating oncologists never suggest follow-up mammography.
Patients tend to be followed in oncology clinics at 3-4-monthly intervals for the first 2 years, 6-monthly in the third and fourth years and, thereafter, yearly.
Fifteen per cent of oncologists discharge patients at 5 years, with the discharge rate rising to 43% at 10 years ; around one-third modify follow-up according to the age of the patient.
Mots-clés Pascal : Tumeur maligne, Glande mammaire, Homme, Surveillance, Méthodologie, Médecin, Pratique professionnelle, Echelon national, Royaume Uni, Europe, Stade précoce, Glande mammaire pathologie
Mots-clés Pascal anglais : Malignant tumor, Mammary gland, Human, Surveillance, Methodology, Physician, Professional practice, National scope, United Kingdom, Europe, Early stage, Mammary gland diseases
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 95-0549590
Code Inist : 002B20E02. Création : 01/03/1996.